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A B S T R A C T
Recent advances in human genetics have revealed a number of genes influencing the susceptibility to obesity and re-
lated conditions, but it is likely that their contribution to disease is contingent on numerous environmental factors. As
the obesity epidemic has occurred over a relatively short period of recent history, use of gene-by-year of birth analysis may
be a useful approach for quantifying, in aggregate, the interaction between genetic susceptibility to obesity and the nu-
merous known and unknown environmental factors that have changed during nutrition and health transitions globally
during this recent increase in obesity rates. Evidence from one family-based longitudinal study set in the United States is
showcased, which points to significant increases in the effect of common genetic variants on childhood and adulthood
BMI over an 80 year period spanning from 1929 to the present. First, common genetic variants previously known to be as-
sociated with age at menarche through genome-wide association analysis were examined in aggregate using a genetic
risk score approach. The menarche genetic risk score, composed of 42 single-nucleotide polymorphisms (SNPs) was sig-
nificantly associated with peri-pubertal BMI in both boys and girls, but the magnitude of the association was strongly de-
pendent on year of birth, with greater effect as birth year increased. Second, a similar approach was taken using instead
a BMI genetic risk score composed of 32 common variants previously found to be associated with BMI. This score was
strongly associated with adulthood BMI, waist circumference, and skinfold thickness, as expected, but the magnitude of
the association increased with later year of birth. Such gene-environment interactions call for greater focus on the mech-
anisms by which environmental factors impact the functional output of the human genome, including how epigenetic
mechanisms may be altered during social, technological, nutritional, and ecological transitions.
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Introduction
Obesity prevalence has increased dramatically over
the past 30 years to 17% of children and 35% of adults in
the United States1; 1.7 billion people around the globe
are overweight and 310 million are obese with rates of
obesity tripling in the last 20 years in poorer countries.
The greatest increases are now in the Middle East,
China, Southeast Asia, and the Pacific islands nations. It
is forecasted that Type 2 Diabetes Mellitus will increase
170% in poorer countries and by 41% in industrialized
countries in the next 20 years2. The transitions in human
nutrition that have driven the increased prevalence of
these diseases are primarily technological in origin. Mass
food production has lead to the lower cost of simple sug-
ars and fats and increased average caloric intakes. The
widespread use of automobiles for transportation and re-
duction in need for manual labor and screen-based enter-
tainment has lowered energy expenditure. Clearly, the
nutritional and lifestyle transition we are witnessing is
not uniform, and there are vast disparities within and
between countries in the rates of undernutrition, infec-
tious disease, and mortality; transitions are complex.
Nonetheless, because of the massive effect of recent envi-
ronmental changes on obesity and health, it might be as-
sumed that the genetic contribution to human variation
is minor and that differences between individuals are
only due to lifestyle factors. After all, allelic frequencies
have not changed within populations over the recent pe-
riod of the obesity epidemic. It is the environment in
which those alleles function that has changed. One might
reasonably question whether genetic variation could
have any major role in the current picture of obesity.
Human Genetics Research in Transition
The field of human genetics has undergone a transi-
tion in parallel with the obesity epidemic. Until 1990, vir-
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tually all human genetic studies were either quantitative
(i.e., looking at similarities within and between relatives
to determine the overall genetic influence), were track-
ing high penetrance variants through families to identify
single gene disorders, or were focused on a small number
of polymorphisms in small numbers of study subjects.
The latter approach, of selecting a small number of vari-
ants in a small number of genes and studying them in a
small number of individuals, essentially did not work for
the multifactorial diseases of greatest public health sig-
nificance, and which have been the outcome of health
transitions worldwide. Numerous genes on every chro-
mosome were reported to be associated with obesity, but
most of these associations were false positives; they were
not replicated in any other studies. Therefore, there was
relatively little insight into the genetic regulation of ap-
petite, satiety, taste, proclivity to exercise, metabolic
rate, and lipid and carbohydrate trafficking in humans.
Since then, an explosion in high-throughput molecular
techniques has reduced the costs of genotyping and gene
expression studies, so that millions of variants can be
tested in one experiment in large numbers of subjects. At
the same time, massive advances in computer processing
speed and complexity and reduction in costs have al-
lowed geneticists to map and deeply scrutinize human
genomic variation. Statistical genetics became far more
sophisticated. Finally, data sharing across institutions
and studies has increased the number of subjects that
can be tested at once. Whereas a very large genetic study
of obesity in 1990 might have included 2,000 individuals,
recent work includes up to a million subjects through col-
laboration of hundreds of scientists.
Genetics of Obesity and other
Chronic Diseases in 2012
What is the result of this epidemic of super-sized ge-
netic research? Using genome-wide association approa-
ches, in which 500,000 to 1 million genetic variants are
examined for association with disease traits or risk fac-
tors in tens or hundreds of thousands of human subjects,
collaborative efforts have identified approximately 32
variants contributing to BMI and obesity3 and 53 influ-
encing glycemic control and diabetes4. Growth and devel-
opment traits have been examined as well – 42 variants
contributing to age at menarche5 and over 180 different,
independent variants contribute to normal variation in
human stature. The good news is that many novel gene
pathways have been identified, which is the first step to-
ward effective pharmaceutical development and also an
important starting place for epidemiology – we are finally
beginning to quantify population-level genetic risks for
disease. In the case of BMI and obesity, for instance,
many of the genes identified are neurotrophic factors in
pathways involved in the central regulation of appetite
and energy expenditure, while fewer are involved in lipid
metabolism. In addition, there are certain regions of the
genome that are now known to be enriched for age-asso-
ciated diseases of transition and reduced longevity (can-
cer, diabetes, obesity, cardiovascular disease)6, while most
of the genome harbors relatively little chronic-disease re-
lated variation.
However, genome-wide association studies are also
somewhat disappointing in that the phenotypic variance
explained by these common polymorphisms is low. Fam-
ily studies repeatedly show that about 50% of the varia-
tion in BMI is due to genetic effects, but the 32 well-repli-
cated BMI and obesity SNPs mentioned above account
for less than 3% of BMI variation and the 180 height
SNPs account for about 10% of human height variation.
This is the so-called »missing heritability« problem, and
may suggest that indeed, genetic variation plays a fairly
minor role in distinguishing individual differences in
health-related traits. However, there is also the possibil-
ity that we are looking in the wrong place for relevant ge-
netic variants7. For example, the field of genetic epidemi-
ology was largely influenced by the »common-disease-
-common variant« theory, in which common diseases
were thought to be influenced by a set of common (minor
allele frequency >5%) variants, and therefore existing
genome-wide arrays only target these common variants.
Rarer variants with larger effect sizes may contribute
greater variance to obesity and other such common dis-
ease traits. Other possibilities are that there are struc-
tural variants such as copy number variants that are not
picked up by existing arrays, and that genetic variants do
not work in isolation but in large networks and so multi-
ple gene-gene interactions must be assessed. It is also
possible that heritability estimates are inflated by shared
environment between relatives. Indeed confounding by
familial environment has been a frequent criticism lev-
eled at genetic studies of normal human variation, and
except for studies of twins reared apart, it is true that
there is little way to segregate environmental and ge-
netic factors in family studies. However, genome-wide
marker data are being used to empirically estimate the
genetic and phenotypic covariance among relatives,
which is not inflated by shared environment as is the
kinship coefficient. Thus far, these estimates appear to
be very similar to traditional heritability estimates8.
Gene-by-Environment Interaction
in Obesity
Another possibility is that to date, environmental het-
erogeneity within and between studies have not been ef-
fectively addressed in large-scale genetic studies, which
have focused first on testing the main effects of genetic
variants. Could taking account of environmental hetero-
geneity improve our understanding of the contribution of
genetic factors to growth and obesity traits? To date, the
best example of gene-by-environment interaction on adi-
posity is the interaction of physical activity (PA) level
with the »fat mass and obesity linked« gene, FTO, discov-
ered via genome-wide association study in 20079 and the
strongest genetic susceptibility locus for obesity yet dis-
covered. With numerous receptors in the arcuate nucleus
of the hypothalamus, FTO functions to regulate appetite
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and energy expenditure10. SNPs found within intron 1 of
FTO are associated with BMI and body fatness across
numerous populations11, and in both children and adults.
However, the association of FTO variants on adiposity
depends on physical activity level, with stronger associa-
tions in individuals with lower PA level. A meta-analysis
of over 200,000 individuals confirmed this interaction in
numerous populations12, where each copy of the risk al-
lele increased the risk of obesity by 30% in low PA indi-
viduals, but by only 20% in high PA individuals. We
found no interaction effect in children.
This finding has large public health implications, as it
is a proof of principle that increased physical activity, a
core strategy for chronic disease prevention, has the po-
tential to counteract the effects of a putatively deleteri-
ous genotype on obesity. However, the meta-analysis in-
teraction effect was nonetheless fairly small and the
study was predominantly restricted to European ances-
try individuals. We recently looked at this question in ap-
proximately 3,000 African Americans (AA) and 7,000 Eu-
ropean Americans (EA) in the Atherosclerosis Risk in
Communities (ARIC) study13. PA was coded as a dichoto-
mous variable (lowest tertile versus middle or highest
tertile) of sports activity. In race- and sex-stratified mod-
els, we found no interaction effect in either AA or EA
women, but found a strong interaction of FTO SNP
rs9939609 by low PA on BMI in both AA men (P=0.001)
and EA men (P=0.036). The interaction of rs9939609 ×
PA was also significant for WC (P=0.0016 in AA men and
P=0.029 in EA men) and for SKF (P=0.0005 in AA men
and P=0.012 in EA men). As shown in Figure 1, the SNP
had a stronger association with adiposity traits in men
with low PA than in men with high PA. In AA men in par-
ticular, the additive per allele effect of the SNP was
nearly 10 times greater in those with low PA than in
those with high PA, and the SNP had no significant in
those with moderate or high sports activity. This sug-
gests that environmental variation may mask genetic ef-
fects when those differences are not accounted for.
Gene-by-Year of Birth as a Type of
Gene-by-Environment Interaction
The results above are for a single variant in interac-
tion with a single environmental factor. While methods
of genome-wide interrogation of gene-environment in-
teraction are ongoing, nonetheless, no single study or
group of studies will have high quality data on all possi-
ble exposures and thus it will be exceedingly difficult to
conduct meta-analysis that will be able to accurately cap-
ture the totality of gene-by-environment effects on a
trait. One approach would be to take advantage of the
known changes over time in numerous aspects of nutri-
tion and energetic during the obesity epidemic. In other
words, with genetic data on individuals from the same
genetically stable population tracked over time, one could
test the hypothesis of gene-by-secular trend interaction.
After adjusting for age effects, the degree to which the
genetic association of genes with adiposity varies with
year of birth would be a measure of global gene-by-envi-
ronment interaction. This idea is supported by the fact
that as the obesity epidemic has continued, increases in
BMI have been seen more at the upper tails of the distri-
bution than in the mean. For example, in children, there
was no increase in median BMI from 1999 to 2008 except
that an increase occurred in boys aged 6-19 years above
the 97th percentile. In adults, this is even clearer; the
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Fig. 1. Interaction between FTO genotype (rs9939609) and physi-
cal activity level (PA) on BMI, Waist Circumference, and sum of
skinfolds in African American and European American men









prevalence of adults with BMI > 50 increased 9-fold be-
tween 1985 and 2005, while the prevalence of adults with
BMI > 30 approximately doubled14. Ravussin and Bou-
chard have presented a helpful conceptual model of this
phenomenon15, and illustrated in Figure 2. Genetic sus-
ceptibility to obesity can be defined as a variable result-
ing from allelic variations at a set of obesity genes in
low-risk (restrictive, left distribution) and high-risk (obe-
sigenic, right distribution) environments. In a »restric-
tive« environment in which caloric availability is limited
and physical activity is high, individuals with a low ge-
netic susceptibility (Obesity Resistant, OR) will have a
very low body mass index and those with a high genetic
susceptibility (Obesity Prone, OP) will have a higher
BMI (higher degree of adiposity). Yet, even those who
were obesity prone will have relatively low BMI com-
pared to the BMI distribution in an »obesigenic« environ-
ment. When these obesity prone individuals move into an
environment replete with high fat foods and low demand
for physical activity, the overall distribution of adiposity
will shift to the right. The same scenario is represented
in the lower panel, showing the presence of a gene × en-
vironment interaction in which the »obesigenic« envi-
ronment amplifies the effects of genetic susceptibility in
obesity prone individuals compared to obesity resistant
individuals.
Gene-by-Year of Birth Interaction Effects
on Childhood and Adulthood BMI in the
Fels Longitudinal Study
The Fels Longitudinal Study includes approximately
1,400 non-Hispanic white subjects born in southwestern
OH and was initiated in 1929 to track individuals from
birth to adulthood for measurement of normative growth
and cardiovascular disease risk factor development. The
Fels Longitudinal Study is a family study, which is now
following a 4th generation of subjects, and has both ge-
nome-wide genotype data and information on BMI and
adiposity traits over the life course in individuals born
from 1929 to the present. This permits examination of
how genetic influences on these traits have changed over
time. Like the surrounding society, child and adulthood
growth and BMI have changed during this period, mir-
roring trends in nutrition in the wider society. For in-
stance, birth weight has increased with increasing ma-
ternal BMI16, and now this has lead to a higher, later age
at peak infant BMI (Johnson et al., personal communica-
tion). Childhood BMI patterns have shifted toward ear-
lier adiposity rebound and faster adolescent BMI gains17,
and age at menarche in girls has declined in the last two
decades from a mean of 12.8 years in girls born between
the 1930’s – 1960’s to a mean of 12.3 years in girls born
in the 1980’s18. In turn, adulthood BMI has increased
over the same period18.
In two recent studies, we have shown that the magni-
tude of these increasing trends in adiposity depend on ge-
notype((Johnson et al., in press); (E. W. Demerath et al.,
in press). First, we calculated a genetic risk score for
early menarche using the 42 well-replicated SNPs re-
ported by Elks et al.5, and a genetic risk score for higher
BMI using the 32 SNPs reported by Speliotes et al., 2010.
That is, for each individual in the study, we counted the
number of alleles for each of these SNPs that was associ-
ated with earlier menarche, and higher BMI, respec-
tively. We then used maximum likelihood-based variance
components analysis to estimate trait heritabilities,
main effects of the genetic risk score (using a 1 df test)
and year of birth (YOB), and the genetic risk score-
-by-YOB interaction, as well as other covariates.
In the first case, we tested whether the menarche ge-
netic risk score was associated with childhood BMI Z
score (WHO standard) in over 500 boys and girls seen
longitudinally during the peripubertal period, from 6
years prior to peak height velocity to 6 years after peak
height velocity, and whether there was a menarche ge-
netic risk score x YOB interaction at each of those ages. A
representative subset of the results are shown in Figure
3. These results examine a more conservative risk score
composed of only 29 SNPs, with deletion of 14 SNPs al-
ready documented to be associated with BMI. Interest-
ingly, there were significant main effects of the genetic
risk score on BMI Z score in both sexes, which suggests
that the menarche variants are related to general growth
and development seen in both sexes and not ovarian de-
velopment only. Second, the genetic risk score had a posi-
tive interaction with year of birth, such that the increase
in BMI Z score per allele increase in the genetic risk score
increased across subsequent decades of birth; this was
true for both pre-pubertal BMI (4 years prior to peak
height velocity) and post-pubertal BMI (4 years after
peak height velocity). We know of no other studies that
have documented such a gene-by-time interaction for
childhood BMI, but the results lend support to the no-
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Fig. 2. Hypothesized differences in the phenotypic impact of the
genetic susceptibility to obesity under obesogenic and restrictive









tion, hypothesized by Ravussin and Bouchard15, among
others, that the epidemic of obesity seen in the past 30
years is at least partially due to alteration in the influ-
ence of genes over time though increases in caloric intake
and lower energy expenditure. The Fels Longitudinal
Study unfortunately does not have data on caloric intake
and physical activity collected systematically over the en-
tire period of the study, making specific behavioral con-
tributors to the interaction difficult or impossible to pin-
point. Nonetheless, our strategy here is to utilize birth
year as a proxy for numerous unmeasured environmen-
tal factors affecting energetics and nutrition over this pe-
riod of time, and our data support the hypothesis of a
change in the influence of developmental timing genes
on childhood BMI.
In the second case20, we tested whether a BMI genetic
risk score was differentially associated with BMI, waist
circumference (WC), sum of four skinfolds, and other
anthropometric measures of adiposity in 907 adults
(measured at 20–60 years of age) born at different points
in time. As expected, significant positive main effects
were observed for both the obesity genetic risk score and
for YOB for most traits; in addition, significant positive
GRS-by-YOB effects were found for BMI (p=0.0001), WC
(p=0.0001), and SKF (p=0.0001). For each 1 allele in-
crease in the genetic risk score, we found an estimated
increase of 0.5 mm in the sum of skinfolds among indi-
viduals born in 1930 compared with an estimated 3 mm
increase among individuals born in 1980. Likewise, the
effect of 1 allele increase on BMI was 0.15 kg/m2 in indi-
viduals born in 1930 and 0.55 kg/m2 in individuals born
in 1980. It is true that there are likely many other addi-
tive genetic variants contributing to adulthood BMI, as
evidenced by significant heritability even after adjusting
for the genetic risk score and its interactions with YOB.
Nonetheless, these novel findings support the hypothesis
that the influence of common obesity susceptibility vari-
ants has increased over the 20th century. Data from
Swedish conscripts also shows that the heritability of
BMI, that is, its genetic variance, has increased over the
same period21. Again, these data suggest that although
environmental factors are primary in driving the obesity
epidemic, the changing environment has altered the ac-
tion of genes. Furthermore, it suggests that if anything,
genetic variants involved in human adiposity have not
declined in influence with nutritional transition, but
rather that their full range of expression may only be
reached with the evolutionarily extreme exposures to
obesogenic environments that we now see.
Epigenetic Modification in Gene-by-Year
of Birth Interactions on Obesity Traits
One possible mechanism that explains how gene ac-
tion can change with changing environmental conditions
is epigenetic modification. Whereas the individual ge-
netic sequence (base pair sequence) is fixed at gamete
formation and is identical in all cells regardless of cell
type, genetic expression varies greatly over the course of
embryogenesis, fetal development, childhood growth,
and aging and varies by cell type. Epigenetics is the study
of chemical changes to the DNA molecule affecting its
conformational structure (euchromatin or chromatin)
and ultimately the transcriptional read-out of the ge-
nome. Addition or subtraction of methyl (CH3) groups to
cytosine residues (DNA methylation) and modification of
the histone bodies around which DNA is coiled (histone
modification) are two processes that change the confor-
mational structure of DNA. Both DNA methylation and
histone modification, among other epigenetic changes,
affect the ability of the transcriptional machinery of the
cell to access a particular segment of the DNA. For exam-
ple, DNA methylation events tend to cluster in areas of
the genome having numerous CG repeats (called CpG is-
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Fig. 3. Estimates effects of an early menarche genetic risk score
on pre-pubertal BMI (4 years prior to peak height velocity) and
post-pubertal BMI(4 years after peak height velocity in boys and










lands), which are often upstream of the promoter region
of genes. This decreases the ability of transcription fac-
tors to bind to the promoter region to initiate transcrip-
tion.
As mentioned above, the epigenetic state of the ge-
nome changes with age; DNA goes through large fluctua-
tions in global demethylation and remethylation during
embryogenesis22, and tends to becomes more hypomethy-
lated with increasing age23. Epigenetic marks are also
modifiable by environmental factors such as the nutrient
content of the diet24, maternal behavior and stress25, and
environmental pollutants22.
At this point, few large human studies of differential
DNA methylation have been conducted, and the environ-
mental determinants of histone modification are even
less explored. However, it is possible that typical patterns
of epigenetic regulation of gene expression in humans
are being altered by shifts in the human environment,
and may be partly responsible for the gene-by-year of
birth interactions on obesity we reported above. A recent
study found that exposure to a high-fat diet was not only
associated with peripheral insulin resistance, but also in-
fluenced DNA methylation of the peroxisome proli-
ferator-activated receptor gamma, coactivator 1-alpha
(PPARGC1A) gene in skeletal muscle27, and a recent
study found differential DNA methylation in obese and
normal weight preadolescents at 20 different loci28. How-
ever, none of these loci included FTO or other known
obesity loci. Rather, it may be that genetic variation that
influences obesity does so by altering epigenetic marks in
neighboring or distant regions of the genome. For exam-
ple, individuals carrying FTO risk alleles have differen-
tial methylation of other genes28, and greater methy-
lation of sites within Intron 1 of the FTO gene itself.
Complex interactions between genetic susceptibility to
obesity (sequence variation), epigenetic changes in and
around obesity genes, and environmental factors are
likely operating. This is a very fertile area for future re-
search, and studies are needed to understand the extent
to which human epigenetic variation is changing during
social and environmental transition. Such work is partic-
ularly important in regions of the world where environ-
mental change is occurring rapidly.
Conclusion
In summary, this essay argues that genes play a major
role in the susceptibility to obesity, but that to further
the field, greater attention must be paid to gene-environ-
ment interaction. Particular emphasis should be placed
on documenting how epigenetic mechanisms may be al-
tered during social, technological, nutritional, and eco-
logical transitions. Evidence from one family-based lon-
gitudinal study set in the United States is showcased,
which points to significant increases in the effect of com-
mon genetic variants on BMI over an 80 year period
spanning from 1929 to the present.
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GENETIKA PRETILOSTI U TRANZICIJI
S A @ E T A K
Recentni napreci u humanoj genetici otkrili su veliki broj gena odgovornih za sklonost pretilosti i srodnim stanjima,
no oni su najvjerojatnije u uskoj vezi i s brojnim okoli{nim utjecajima. S obzirom na brzi razvoj epidemije pretilosti u
posljednje vrijeme, analize koje mogu kvantificirati interakciju geneti~ke predispozicije za pretilost i brojnih poznatih i
jo{ nepoznatih okoli{nih faktora koji su se javili sa prehrambenom i zdravstvenom tranzicijom pokazale su se vrlo
korisnima. Dokaz su pru`ile longitudinalne studije provedene na obiteljima u SAD-u u razdoblju od 80 godina (od 1929.
do danas), koje upu}uju na zna~ajan porast utjecaja uobi~ajenih genskih varijanti na indeks tjelesne mase djece i odras-
lih. Istra`ivane su uobi~ajene genske varijante za koje su asocijacijske studije koje obuhva}aju cijeli genom pokazale da
su povezane s dobi menarhe i to koriste}i vi{e geneti~kih markera s ciljem otkrivanja stupnja rizika. Pokazalo se da je
geneti~ki marker rizika za dob nastupanja menarhe, koji se sastoji od 42 polimorfizma jednog nukleotida, zna~ajno
povezan s pubertetskim indeksom tjelesne mase i kod dje~aka i kod djevoj~ica, no i da stupanj povezanosti znatno ovisi o
godini ro|enja pojedinca te da se povezanost pove}ava s pove}anjem godine ro|enja. Tako|er, isti je pristup kori{ten i sa
geneti~kim markerom rizika za indeks tjelesne mase, koji se sastoji od 32 uobi~ajene genske varijante, a za koji je
utvr|ena povezanost sa mjerenim indeksom tjelesne mase. O~ekivano, utvr|en je visok stupanj njegove povezanosti s
indeksom tjelesne mase odraslih osoba, opsegom struka i debljinom ko`nih nabora, no stupanj povezanosti je bio tri
puta ve}i kod pojedinaca ro|enih 1980., nego kod onih ro|enih 1930. godine. Takva interakcija gena i okoli{a upu}uje
na veliku va`nost mehanizama putem kojih okoli{ni ~imbenici utje~u na funkcionalnost ljudskog genoma te nam govori
kako se epigeneti~ki mehanizmi mogu mijenjati tijekom dru{tvenih, tehnolo{kih, prehrambenih i ekolo{kih tranzicija.
E. W. Demerath: The Genetics of Obesity in Transition, Coll. Antropol. 36 (2012) 4: 1161–1168
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